SCHEMBL8736800

SCHEMBL8736800

CCCCCCOP1(=O)OCCO1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
CDC25A P30304 1/20 0.36
CA1 P00915 5/20 0.35
CA2 P00918 5/20 0.35
CA9 Q16790 5/20 0.35
LPAR3 Q9UBY5 3/20 0.35
LPAR1 Q92633 2/20 0.35
LPAR2 Q9HBW0 2/20 0.35
NAAA Q02083 1/20 0.35
CA12 O43570 1/20 0.35
CA3 P07451 1/20 0.35
CA4 P22748 1/20 0.35
CA6 P23280 1/20 0.35
CA5A P35218 1/20 0.35
CA7 P43166 1/20 0.35
CA14 Q9ULX7 1/20 0.35
CA5B Q9Y2D0 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26518724 1.00 ALDH1A1 (0.36) ALDH1A1TDP1CDC25ACA1CA2
SCHEMBL26518736 1.00 ALDH1A1 (0.36) ALDH1A1TDP1CDC25ACA1CA2
SCHEMBL26518731 1.00 ALDH1A1 (0.36) ALDH1A1TDP1CDC25ACA1CA2
SCHEMBL26518741 1.00 ALDH1A1 (0.36) ALDH1A1TDP1CDC25ACA1CA2
SCHEMBL11567393 1.00 ALDH1A1 (0.36) ALDH1A1TDP1CDC25ACA1CA2
SCHEMBL26518755 1.00 ALDH1A1 (0.36) ALDH1A1TDP1CDC25ACA1CA2
SCHEMBL26518728 1.00 ALDH1A1 (0.36) ALDH1A1TDP1CDC25ACA1CA2
SCHEMBL9056245 1.00 ALDH1A1 (0.36) ALDH1A1TDP1CDC25ACA1CA2
SCHEMBL26518750 1.00 ALDH1A1 (0.36) ALDH1A1TDP1CDC25ACA1CA2
SCHEMBL11570499 1.00 ALDH1A1 (0.36) ALDH1A1TDP1CDC25ACA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113181359-B Magnetocaloric-immunity combined medicine and application thereof 华南理工大学 2023-06-20 CN claimed
US-20230320994-A1 FUNCTIONAL IONIZABLE PHOSPHOLIPIDS THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2023-10-12 US disclosed
US-20230320994-A1 FUNCTIONAL IONIZABLE PHOSPHOLIPIDS THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2023-10-12 US disclosed
WO-2023108227-A1 SAFE STORAGE OF LIQUID ACIDIC REAGENTS ATH (AUSTRALIA) PTY LTD (AU) 2023-06-22 WO disclosed
CN-113181359-B Magnetocaloric-immunity combined medicine and application thereof 华南理工大学 2023-06-20 CN disclosed
US-5723558-A MONOMERS OR MEDICAL MATERIAL, BIOSENSORS AND COSMETICS NOF CORPORATION (JP) 1998-03-03 US disclosed
EP-0790252-A1 FUMARIC ACID DERIVATIVE AND POLYMER THEREOF NOF CORPORATION (JP) 1997-08-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230320994-A1 FUNCTIONAL IONIZABLE PHOSPHOLIPIDS PHOSPHO1, PLA2G2C, PLTP ALDH1A1 4672/4885TDP1 577/4885CDC25A 3546/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.